Heart Doc VIP with Dr. Joel Kahn Episode 468: A Trip to the American Heart Association Meeting 2025
12 snips
Nov 18, 2025 Discover the latest breakthroughs from the American Heart Association meeting! Exciting findings include a polypill for heart failure that boosts adherence, and how coffee may reduce atrial fibrillation recurrence. Advances in gene editing to lower cholesterol spark intrigue, while an oral PCSK9 inhibitor shows promise. Early mitral valve repairs can greatly improve survival rates. Plus, new research on tadalafil suggests potential benefits for reducing mortality and dementia. Tune in for these vital health insights!
AI Snips
Chapters
Transcript
Episode notes
Personal Endorsement Of Tryauri Products
- Joel Kahn endorses Tryauri mushroom elixirs and takes them in his coffee.
- He praises their clean ingredients and the founder Evan, urging listeners to try them.
Combine Statin With Ezetimibe For Better LDL
- Add ezetimibe to rosuvastatin when LDL remains above target rather than simply increasing statin dose.
- Combination therapy often achieves LDL <70 mg/dL with no extra side effects.
Early Mitral Repair Improves Long‑Term Survival
- Early mitral valve repair in asymptomatic severe regurgitation improved 12‑year survival and reduced heart failure.
- Early surgery lowered cumulative mortality from 10.4% to 1.5% versus conservative care.